Seelos Therapeutics Inc (SEEL)

Shares of Seelos Therapeutics Inc (SEEL) dropped by 47.48% from $2.38 to $1.25 in the trading on Wednesday, November 29, 2023. The reason why SEEL is down today is due to the company's announcement of a significant public offering. The offering included 1,781,934 shares of common stock, pre-funded warrants for up to 2,422,612 common stock shares, and accompanying common warrants for up to 4,204,546 common stock shares. Each common stock share, paired with an accompanying common warrant for an additional share, was offered at a combined public price of $1.32 per unit. Pre-funded warrants, along with accompanying common warrants to purchase common stock, were priced at $1.319 per pre-funded warrant and accompanying common warrant.

Seelos Therapeutics Inc Stock (SEEL) dropped by 25.44% from $3.19 to $2.38 in the trading on Tuesday November 28, 2023. The reason why SEEL stock down today is due to the announcement of stock split: Seelos effected a 1-for-30 reverse stock split, with the split-adjusted shares slated to begin trading Tuesday morning. The company said it conducted the split to regain compliance with Nasdaq’s minimum bid price requirements.

Seelos Therapeutics, Inc. (SEEL) fell 37.73% to $0.19 after the company announced a $4.5 million registered direct offering of common stock and warrants to purchase common stock. Guggenheim downgraded Seelos Therapeutics from Buy to Neutral.

https://www.benzinga.com/news/23/09/34801298/why-seelos-therapeutics-shares-are-trading-lower-by-31-here-are-other-stocks-moving-in-thursdays-mid